Valentina Capo
Staff Scientist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Immunodeficient mouse strains are widely used in several fields of biomedical research. Despite that, no standardized system for evaluating immunodeficiency in mice currently exists, and an unbiased comparison of various immunodeficient mouse strains is difficult. The aim of our study was to develop a standardized multi-disciplinary protocol for the morpho-phenotypical assessment of immunodeficient mouse models. We selected 4 immunodeficient strains of mice ( Cd40l -/- , Was -/- , Rag1 R972Q/R972Q , and Rag1 -/- ) on a C57BL/6J genetic background and a group of control C57BL/6J wild-type mice. The lymphoid organs were harvested, weighed, and analyzed by histology, immunohistochemistry, and flow cytometry. Hematology and bone marrow cytology were also performed. The main immune cell populations were investigated, including lymphocytes, monocytes/macrophages, neutrophils, and natural killer cells. Relative organ weights were lower in the strains with the highest level of immunodeficiency ( Rag1 R972Q/R972Q and Rag1 -/- ). Histology revealed overall lower cellularity in the same strains, particularly in Rag1 -/- mice. Tissue spatial distributions of the immune cell populations were confirmed by immunohistochemistry, while flow cytometry allowed for their relative quantification. Likewise, hematology detected moderate lymphopenia in the Rag1 R972Q/R972Q mice and more severe lymphopenia in Rag1 -/- mice. Our protocol has proven itself effective for the morpho-phenotypical assessment of the immunodeficient mouse models under investigation and was useful in characterizing the type and severity of the defects. The different laboratory techniques were consistent in the characterization and confirmation of immunodeficiency in the different strains, providing different complementary insights.
Year:
2026
Year:
2025
The Cd40l –/– mouse is a well-established model of X-linked hyper-immunoglobulin M (IgM) syndrome, an immunodeficiency disorder of human beings characterized by the lack of expression of the CD40 ligand (CD40L) on activated T-cells, predisposing to infections with opportunistic pathogens like Pneumocystis jirovecii. The aim of our study was to describe the pulmonary lesions in Cd40l –/– mice experimentally infected with Pneumocystis murina, in comparison with naturally infected severe combined immunodeficient (SCID) mice. Formalin-fixed paraffin-embedded lungs from 26 Cd40l –/– , 11 SCID, and 5 uninfected Cd40l –/– mice were examined by histology and immunohistochemistry for the presence of the pathogen and for leukocyte populations (CD3, CD4, CD45R/B220, CD8a, Iba-1, Ly-6G, CD206, MHC II, and NKp46/NCR1). Infection was confirmed by immunohistochemistry in 18/26 (69%) Cd40l –/– mice and in 11/11 (100%) SCID mice. Fourteen out of 26 (54%) Cd40l –/– mice had interstitial pneumonia. Twenty-three out of 26 (88%) Cd40l –/– mice had peribronchiolar/perivascular lymphoplasmacytic infiltrates, rich in B-cells and Mott cells. Acidophilic macrophage pneumonia was additionally found in 20/26 (77%) Cd40l –/– mice. Only 4/11 (36%) SCID mice had interstitial pneumonia, but no peribronchiolar/perivascular infiltrates or acidophilic macrophage pneumonia were observed in this strain. This study represents the first description of pulmonary histopathological lesions in Cd40l –/– mice infected with P. murina. We speculate that the singular characteristics of the inflammatory infiltrates observed in Cd40l –/– mice could be explained by the specific immune phenotype of the model.
Year:
2024
Introduction Autosomal recessive osteopetrosis (ARO) is a rare genetic disease, characterized by increased bone density due to defective osteoclast function. Most of the cases are due to TCIRG1 gene mutation, leading to severe bone phenotype and death in the first years of life. The standard therapy is the hematopoietic stem cell transplantation (HSCT), but its success is limited by several constraints. Conversely, gene therapy (GT) could minimize the immune-mediated complications of allogeneic HSCT and offer a prompt treatment to these patients. Methods The Tcirg1 -defective oc/oc mouse model displays a short lifespan and high bone density, closely mirroring the human condition. In this work, we exploited the oc/oc neonate mice to optimize the critical steps for a successful therapy. Results First, we showed that lentiviral vector GT can revert the osteopetrotic bone phenotype, allowing long-term survival and reducing extramedullary haematopoiesis. Then, we demonstrated that plerixafor-induced mobilization can further increase the high number of HSPCs circulating in peripheral blood, facilitating the collection of adequate numbers of cells for therapeutic purposes. Finally, pre-transplant non-genotoxic conditioning allowed the stable engraftment of HSPCs, albeit at lower level than conventional total body irradiation, and led to long-term survival and correction of bone phenotype, in the absence of acute toxicity. Conclusion These results will pave the way to the implementation of an effective GT protocol, reducing the transplant-related complication risks in the very young and severely affected ARO patients.
Year:
2024
Year:
2023
Year:
2023
Collaborators (4)
Antonella Forlino
University of Pavia
Chiara Brombin
Assistant Professor in Statistics SECS-S/01 (RTD-B)
Università Vita Salute San Raffaele
Luca Bertola
University of Milan
Alessio Cantore
Group Leader
San Raffaele Telethon Institute for Gene Therapy
Make your next move.
Prepare your application
Review drafts before you send them.